世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global COPD Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1582 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、COPD治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、PDE-4阻害薬、ステロイド、併用療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・COPD治療薬の市場動向 ・企業の競争状況、市場シェア ・COPD治療薬の種類別市場規模（気管支拡張薬、PDE-4阻害薬、ステロイド、併用療法、その他） ・COPD治療薬の用途別市場規模（病院、クリニック、その他） ・COPD治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・COPD治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・COPD治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・COPD治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・COPD治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、GlaxoSmithKline、Merck、Abbott Laboratories、Boehringer Ingelheim、AstraZeneca、Roche Holding AG、Teva Pharmaceutical Industries、Vectura Group、Mylan NV） ・結論

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc.
One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.

Market Analysis and Insights: Global COPD Drugs Market
The global COPD Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COPD Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COPD Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COPD Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COPD Drugs market.

Global COPD Drugs Scope and Market Size
COPD Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COPD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bronchodilators
1.2.3 PDE-4 Inhibitors
1.2.4 Steroids
1.2.5 Combination Therapies
1.2.6 Others
1.3 Market by Application
1.3.1 Global COPD Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global COPD Drugs Market Perspective (2016-2027)
2.2 COPD Drugs Growth Trends by Regions
2.2.1 COPD Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 COPD Drugs Historic Market Share by Regions (2016-2021)
2.2.3 COPD Drugs Forecasted Market Size by Regions (2022-2027)
2.3 COPD Drugs Industry Dynamic
2.3.1 COPD Drugs Market Trends
2.3.2 COPD Drugs Market Drivers
2.3.3 COPD Drugs Market Challenges
2.3.4 COPD Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top COPD Drugs Players by Revenue
3.1.1 Global Top COPD Drugs Players by Revenue (2016-2021)
3.1.2 Global COPD Drugs Revenue Market Share by Players (2016-2021)
3.2 Global COPD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COPD Drugs Revenue
3.4 Global COPD Drugs Market Concentration Ratio
3.4.1 Global COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Drugs Revenue in 2020
3.5 COPD Drugs Key Players Head office and Area Served
3.6 Key Players COPD Drugs Product Solution and Service
3.7 Date of Enter into COPD Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COPD Drugs Breakdown Data by Type
4.1 Global COPD Drugs Historic Market Size by Type (2016-2021)
4.2 Global COPD Drugs Forecasted Market Size by Type (2022-2027)

5 COPD Drugs Breakdown Data by Application
5.1 Global COPD Drugs Historic Market Size by Application (2016-2021)
5.2 Global COPD Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America COPD Drugs Market Size (2016-2027)
6.2 North America COPD Drugs Market Size by Type
6.2.1 North America COPD Drugs Market Size by Type (2016-2021)
6.2.2 North America COPD Drugs Market Size by Type (2022-2027)
6.2.3 North America COPD Drugs Market Size by Type (2016-2027)
6.3 North America COPD Drugs Market Size by Application
6.3.1 North America COPD Drugs Market Size by Application (2016-2021)
6.3.2 North America COPD Drugs Market Size by Application (2022-2027)
6.3.3 North America COPD Drugs Market Size by Application (2016-2027)
6.4 North America COPD Drugs Market Size by Country
6.4.1 North America COPD Drugs Market Size by Country (2016-2021)
6.4.2 North America COPD Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe COPD Drugs Market Size (2016-2027)
7.2 Europe COPD Drugs Market Size by Type
7.2.1 Europe COPD Drugs Market Size by Type (2016-2021)
7.2.2 Europe COPD Drugs Market Size by Type (2022-2027)
7.2.3 Europe COPD Drugs Market Size by Type (2016-2027)
7.3 Europe COPD Drugs Market Size by Application
7.3.1 Europe COPD Drugs Market Size by Application (2016-2021)
7.3.2 Europe COPD Drugs Market Size by Application (2022-2027)
7.3.3 Europe COPD Drugs Market Size by Application (2016-2027)
7.4 Europe COPD Drugs Market Size by Country
7.4.1 Europe COPD Drugs Market Size by Country (2016-2021)
7.4.2 Europe COPD Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific COPD Drugs Market Size (2016-2027)
8.2 Asia-Pacific COPD Drugs Market Size by Type
8.2.1 Asia-Pacific COPD Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific COPD Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific COPD Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific COPD Drugs Market Size by Application
8.3.1 Asia-Pacific COPD Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific COPD Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific COPD Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific COPD Drugs Market Size by Region
8.4.1 Asia-Pacific COPD Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific COPD Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America COPD Drugs Market Size (2016-2027)
9.2 Latin America COPD Drugs Market Size by Type
9.2.1 Latin America COPD Drugs Market Size by Type (2016-2021)
9.2.2 Latin America COPD Drugs Market Size by Type (2022-2027)
9.2.3 Latin America COPD Drugs Market Size by Type (2016-2027)
9.3 Latin America COPD Drugs Market Size by Application
9.3.1 Latin America COPD Drugs Market Size by Application (2016-2021)
9.3.2 Latin America COPD Drugs Market Size by Application (2022-2027)
9.3.3 Latin America COPD Drugs Market Size by Application (2016-2027)
9.4 Latin America COPD Drugs Market Size by Country
9.4.1 Latin America COPD Drugs Market Size by Country (2016-2021)
9.4.2 Latin America COPD Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa COPD Drugs Market Size (2016-2027)
10.2 Middle East & Africa COPD Drugs Market Size by Type
10.2.1 Middle East & Africa COPD Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa COPD Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa COPD Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa COPD Drugs Market Size by Application
10.3.1 Middle East & Africa COPD Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa COPD Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa COPD Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa COPD Drugs Market Size by Country
10.4.1 Middle East & Africa COPD Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa COPD Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer COPD Drugs Introduction
11.1.4 Pfizer Revenue in COPD Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis COPD Drugs Introduction
11.2.4 Novartis Revenue in COPD Drugs Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline COPD Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck COPD Drugs Introduction
11.4.4 Merck Revenue in COPD Drugs Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories COPD Drugs Introduction
11.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim COPD Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca COPD Drugs Introduction
11.7.4 AstraZeneca Revenue in COPD Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG COPD Drugs Introduction
11.8.4 Roche Holding AG Revenue in COPD Drugs Business (2016-2021)
11.8.5 Roche Holding AG Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries COPD Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Vectura Group
11.10.1 Vectura Group Company Details
11.10.2 Vectura Group Business Overview
11.10.3 Vectura Group COPD Drugs Introduction
11.10.4 Vectura Group Revenue in COPD Drugs Business (2016-2021)
11.10.5 Vectura Group Recent Development
11.11 Mylan NV
11.11.1 Mylan NV Company Details
11.11.2 Mylan NV Business Overview
11.11.3 Mylan NV COPD Drugs Introduction
11.11.4 Mylan NV Revenue in COPD Drugs Business (2016-2021)
11.11.5 Mylan NV Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global COPD Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bronchodilators
Table 3. Key Players of PDE-4 Inhibitors
Table 4. Key Players of Steroids
Table 5. Key Players of Combination Therapies
Table 6. Key Players of Others
Table 7. Global COPD Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global COPD Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global COPD Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global COPD Drugs Market Share by Regions (2016-2021)
Table 11. Global COPD Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global COPD Drugs Market Share by Regions (2022-2027)
Table 13. COPD Drugs Market Trends
Table 14. COPD Drugs Market Drivers
Table 15. COPD Drugs Market Challenges
Table 16. COPD Drugs Market Restraints
Table 17. Global COPD Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global COPD Drugs Market Share by Players (2016-2021)
Table 19. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drugs as of 2020)
Table 20. Ranking of Global Top COPD Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by COPD Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players COPD Drugs Product Solution and Service
Table 24. Date of Enter into COPD Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global COPD Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global COPD Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global COPD Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global COPD Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global COPD Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global COPD Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global COPD Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific COPD Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific COPD Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa COPD Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa COPD Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa COPD Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa COPD Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa COPD Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa COPD Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer COPD Drugs Product
Table 67. Pfizer Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis COPD Drugs Product
Table 72. Novartis Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline COPD Drugs Product
Table 77. GlaxoSmithKline Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck COPD Drugs Product
Table 82. Merck Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories COPD Drugs Product
Table 87. Abbott Laboratories Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 88. Abbott Laboratories Recent Development
Table 89. Boehringer Ingelheim Company Details
Table 90. Boehringer Ingelheim Business Overview
Table 91. Boehringer Ingelheim COPD Drugs Product
Table 92. Boehringer Ingelheim Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 93. Boehringer Ingelheim Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca COPD Drugs Product
Table 97. AstraZeneca Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Roche Holding AG Company Details
Table 100. Roche Holding AG Business Overview
Table 101. Roche Holding AG Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 102. Roche Holding AG Recent Development
Table 103. Teva Pharmaceutical Industries Company Details
Table 104. Teva Pharmaceutical Industries Business Overview
Table 105. Teva Pharmaceutical Industries COPD Drugs Product
Table 106. Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 107. Teva Pharmaceutical Industries Recent Development
Table 108. Vectura Group Company Details
Table 109. Vectura Group Business Overview
Table 110. Vectura Group COPD Drugs Product
Table 111. Vectura Group Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 112. Vectura Group Recent Development
Table 113. Mylan NV Company Details
Table 114. Mylan NV Business Overview
Table 115. Mylan NV COPD Drugs Product
Table 116. Mylan NV Revenue in COPD Drugs Business (2016-2021) & (US$ Million)
Table 117. Mylan NV Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Drugs Market Share by Type: 2020 VS 2027
Figure 2. Bronchodilators Features
Figure 3. PDE-4 Inhibitors Features
Figure 4. Steroids Features
Figure 5. Combination Therapies Features
Figure 6. Others Features
Figure 7. Global COPD Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. COPD Drugs Report Years Considered
Figure 12. Global COPD Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global COPD Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global COPD Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global COPD Drugs Market Share by Regions (2022-2027)
Figure 16. Global COPD Drugs Market Share by Players in 2020
Figure 17. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by COPD Drugs Revenue in 2020
Figure 19. Global COPD Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global COPD Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America COPD Drugs Market Share by Type (2016-2027)
Figure 23. North America COPD Drugs Market Share by Application (2016-2027)
Figure 24. North America COPD Drugs Market Share by Country (2016-2027)
Figure 25. United States COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe COPD Drugs Market Share by Type (2016-2027)
Figure 29. Europe COPD Drugs Market Share by Application (2016-2027)
Figure 30. Europe COPD Drugs Market Share by Country (2016-2027)
Figure 31. Germany COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific COPD Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific COPD Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific COPD Drugs Market Share by Region (2016-2027)
Figure 41. China COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America COPD Drugs Market Share by Type (2016-2027)
Figure 49. Latin America COPD Drugs Market Share by Application (2016-2027)
Figure 50. Latin America COPD Drugs Market Share by Country (2016-2027)
Figure 51. Mexico COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa COPD Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa COPD Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa COPD Drugs Market Share by Country (2016-2027)
Figure 57. Turkey COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE COPD Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 67. Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 68. Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 69. Vectura Group Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 70. Mylan NV Revenue Growth Rate in COPD Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---